| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cellular Oncology Group, Institute for Biological Sciences, National Research Council of Canada, Ottawa, Canada K1A 0R6
The effects of topoisomerase II-reactive epipodophyllotoxins etoposide and teniposide as well as amsacrine on the viability of thymocytes in primary culture has been examined. All three drugs were shown to produce DNA cleavage detectable by resolving isolated DNA by pulsed field agarose gel electrophoresis. The DNA cleavage was found to have two components. The first was due to the interaction of the drugs with topoisomerase II, whereas the second component was due to endonuclease cleavage caused by the drug-induced entry of the thymocytes into programmed cell death or apoptosis. This second component of the DNA cleavage was also detected in thymocytes undergoing apoptosis following exposure to the glucocorticoid analogue, dexamethasone. The effect of the drugs on programmed cell death is dependent upon new protein and RNA synthesis, indicating that topoisomerase II has a role in the very first stages of the process. These results are discussed in terms of the use of this class of topoisomerase II-reactive drugs in chemotherapy.
1 This paper is published as National Research Council of Canada publication 31904.
2 To whom requests for reprints should be addressed, at Cellular Oncology Group, Institute for Biological Sciences, National Research Council. Bldg. M54, Montreal Road, Ottawa, Ontario, Canada K1A 0R6.
Received 8/22/90. Accepted 11/19/90.
This article has been cited by other articles:
|
|
 |
|
  T. Oyama, Y. Yamada, K. Hata, H. Tomita, A. Hirata, H. Sheng, A. Hara, H. Aoki, T. Kunisada, S. Yamashita, et al. Further upregulation of {beta}-catenin/Tcf transcription is involved in the development of macroscopic tumors in the colon of ApcMin/+ mice Carcinogenesis, March 1, 2008; 29(3): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Villalba, C. Gomez, O. Medel, V. Sanchez, J. C. Carrero, M. Shibayama, and D. G. P. Ishiwara Programmed cell death in Entamoeba histolytica induced by the aminoglycoside G418 Microbiology, November 1, 2007; 153(11): 3852 - 3863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Takashina and M. Nakayama Modifications enhance the apoptosis-inducing activity of FADD Mol. Cancer Ther., June 1, 2007; 6(6): 1793 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Darnowski, F. A. Goulette, Y.-j. Guan, D. Chatterjee, Z.-F. Yang, L. P. Cousens, and Y. E. Chin Stat3 Cleavage by Caspases: IMPACT ON FULL-LENGTH Stat3 EXPRESSION, FRAGMENT FORMATION, AND TRANSCRIPTIONAL ACTIVITY J. Biol. Chem., June 30, 2006; 281(26): 17707 - 17717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Yakovlev, S. Di Giovanni, G. Wang, W. Liu, B. Stoica, and A. I. Faden BOK and NOXA Are Essential Mediators of p53-dependent Apoptosis J. Biol. Chem., July 2, 2004; 279(27): 28367 - 28374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. O'Nions and M. J. Allday Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens J. Gen. Virol., April 1, 2004; 85(4): 881 - 895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Faderl, P. F. Thall, H. M. Kantarjian, M. Talpaz, D. Harris, Q. Van, M. Beran, S. M. Kornblau, S. Pierce, and Z. Estrov Caspase 2 and Caspase 3 as Predictors of Complete Remission and Survival in Adults with Acute Lymphoblastic Leukemia Clin. Cancer Res., December 1, 1999; 5(12): 4041 - 4047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Aw Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine Am. J. Clinical Nutrition, October 1, 1999; 70(4): 557 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. ASAINZ, J. C. MAYO, R. J. REITER, I. ANTOLÍN, M. M. ESTEBAN, and C. RODRÍGUEZ Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus FASEB J, September 1, 1999; 13(12): 1547 - 1556. [Abstract] [Full Text]
|
|
|
|
 |
|
 A.-T. Sane and R. Bertrand Caspase Inhibition in Camptothecin-treated U-937 Cells Is Coupled with a Shift from Apoptosis to Transient G1 Arrest Followed by Necrotic Cell Death Cancer Res., August 1, 1999; 59(15): 3565 - 3569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. C. Plaat, W. M. Molenaar, M. F. Mastik, J. Koudstaal, E. v. den Berg, H. S. Koops, and H. J. Hoekstra Hyperthermic Isolated Limb Perfusion with Tumor Necrosis Factor-{{alpha}} and Melphalan in Patients with Locally Advanced Soft Tissue Sarcomas: Treatment Response and Clinical Outcome Related to Changes in Proliferation and Apoptosis Clin. Cancer Res., July 1, 1999; 5(7): 1650 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-K. Li, A. Y. Chen, C. Yu, Y. Mao, H. Wang, and L. F. Liu Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress Genes & Dev., June 15, 1999; 13(12): 1553 - 1560. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. M. Kasof, L. Goyal, and E. White Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins Mol. Cell. Biol., June 1, 1999; 19(6): 4390 - 4404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ishiyama, M. Hiroe, T. Nishikawa, T. Shimojo, S. Abe, H. Fujisaki, H. Ito, K. Yamakawa, N. Kobayashi, T. Kasajima, et al. The Fas/Fas Ligand System Is Involved in the Pathogenesis of Autoimmune Myocarditis in Rats J. Immunol., November 1, 1998; 161(9): 4695 - 4701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sabourin, J. A. W. Byl, S. E. Hannah, J. L. Nitiss, and N. Osheroff A Mutant Yeast Topoisomerase II (top2G437S) with Differential Sensitivity to Anticancer Drugs in the Presence and Absence of ATP J. Biol. Chem., October 30, 1998; 273(44): 29086 - 29092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. King and S. Goodbourn STAT1 Is Inactivated by a Caspase J. Biol. Chem., April 10, 1998; 273(15): 8699 - 8704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Sodja, D. Brown, P. Walker, and N Chaly Splenic T lymphocytes die preferentially during heat-induced apoptosis: NuMA reorganization as a marker J. Cell Sci., January 8, 1998; 111(16): 2305 - 2313. [Abstract] [PDF]
|
|
|
|
|
|
K.'i. Imanishi, K. Seo, H. Kato, T. Miyoshi-Akiyama, R.-H. Zhang, Y. Takanashi, Y. Imai, and T. Uchiyama Post-Thymic Maturation of Migrating Human Thymic Single-Positive T Cells: Thymic CD1a- CD4+ T Cells Are More Susceptible to Anergy Induction by Toxic Shock Syndrome Toxin-1 than Cord Blood CD4+ T Cells J. Immunol., January 1, 1998; 160(1): 112 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Q. Wang, L. Stingl, C. Morrison, M. Jantsch, M. Los, K. Schulze-Osthoff, and E. F. Wagner PARP is important for genomic stability but dispensable in apoptosis Genes & Dev., September 15, 1997; 11(18): 2347 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. A. Hannun Apoptosis and the Dilemma of Cancer Chemotherapy Blood, March 15, 1997; 89(6): 1845 - 1853. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Thomaidou, M. C. Mione, J. F. R. Cavanagh, and J. G. Parnavelas Apoptosis and Its Relation to the Cell Cycle in the Developing Cerebral Cortex J. Neurosci., February 1, 1997; 17(3): 1075 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhou, L. Qian, K. M. Kozopas, and R. W. Craig Mcl-1, a Bcl-2 Family Member, Delays the Death of Hematopoietic Cells Under a Variety of Apoptosis-Inducing Conditions Blood, January 15, 1997; 89(2): 630 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Hande The Importance of Drug Scheduling in Cancer Chemotherapy: Etoposide as an Example Oncologist, August 1, 1996; 1(4): 234 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fraser, S. Tynan, A Papaioannou, C. Ireland, and S. Pittman Endo-exonuclease of human leukaemic cells: evidence for a role in apoptosis J. Cell Sci., January 9, 1996; 109(9): 2343 - 2360. [Abstract] [PDF]
|
|
|
|
|
|
V. Weaver, C. Carson, P. Walker, N Chaly, B Lach, Y Raymond, D. Brown, and M Sikorska Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes J. Cell Sci., January 1, 1996; 109(1): 45 - 56. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Hande The importance of drug scheduling in cancer chemotherapy: etoposide as an example Stem Cells, January 1, 1996; 14(1): 18 - 24. [Abstract]
|
|
|
|
 |
|
 P. Hamet, L. Richard, T.-V. Dam, E. Teiger, S. N. Orlov, L. Gaboury, F. Gossard, and J. Tremblay Apoptosis in Target Organs of Hypertension Hypertension, October 1, 1995; 26(4): 642 - 648. [Abstract] [Full Text]
|
|
|
|
|
|
W Ongkeko, D. Ferguson, A. Harris, and C Norbury Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage J. Cell Sci., January 8, 1995; 108(8): 2897 - 2904. [Abstract] [PDF]
|
|
|
|
|
|
A Di Leonardo, S P Linke, K Clarkin, and G M Wahl DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev., November 1, 1994; 8(21): 2540 - 2551. [Abstract] [PDF]
|
|
|
|
|
|
S Cornillon, C Foa, J Davoust, N Buonavista, J. Gross, and P Golstein Programmed cell death in Dictyostelium J. Cell Sci., January 10, 1994; 107(10): 2691 - 2704. [Abstract] [PDF]
|
|
|
|
|
|
G. Bicknell, R. Snowden, and G. Cohen Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937 J. Cell Sci., January 9, 1994; 107(9): 2483 - 2489. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
